PICTON MAHONEY ASSET MANAGEMENT - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 47 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PICTON MAHONEY ASSET MANAGEMENT ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2022$2,778
-99.9%
274,9950.0%0.13%
+33.7%
Q3 2022$2,727,000
+1.3%
274,9950.0%0.10%
-4.9%
Q2 2022$2,692,000
+0.3%
274,9950.0%0.10%
+8.4%
Q1 2022$2,685,000
+121.5%
274,995
+120.0%
0.10%
+216.7%
Q4 2021$1,212,000
-0.4%
124,9980.0%0.03%
-33.3%
Q3 2021$1,217,000
+0.2%
124,9980.0%0.04%
+28.6%
Q2 2021$1,214,000124,9980.04%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Exos Asset Management LLC 45,300$441,0000.23%
MMCAP International Inc. SPC 250,000$2,435,0000.12%
Atalaya Capital Management LP 40,000$386,0000.10%
Radcliffe Capital Management, L.P. 200,000$1,942,0000.06%
Arena Capital Advisors, LLC- CA 75,000$731,0000.06%
FIR TREE CAPITAL MANAGEMENT LP 150,000$1,449,0000.05%
Athanor Capital, LP 147,800$1,428,0000.05%
Woodline Partners LP 275,000$2,654,0000.05%
Ghisallo Capital Management LLC 125,000$1,208,0000.05%
SUVRETTA CAPITAL MANAGEMENT, LLC 300,000$2,922,0000.04%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders